• Horticultural Science & Technology
• /
• v.28 no.6
• /
• pp.948-953
• /
• 2010

We evaluated the bioactive compounds including carbohydrates (CH), organic acids (OA), ascorbic acid (AA), anthocyanin (AC), and ellagic acid (EA) in the achenes, epidermis, and flesh of fully ripe strawberry fruits of the 'Maehyang', 'Seolhyang', 'Keumhyang', 'Akiheme', and 'Red pearl' cultivars. The total contents of CH, OA, AA, and AC were significantly greater in the epidermis than in other tissues, while the EA content was significantly greater in the achenes than in other tissues. The AA content of the epidermis ranged from $49.1-69.2mg{\cdot}100g^{-1}$ FW and was significantly greater than the content of the flesh, while AA was not detected in the achenes of any of the tested strawberry cultivars. The AA contents of the epidermis and flesh of the 'Maehyang' were 69.2 and $42.2mg{\cdot}100g^{-1}$ FW, respectively, and were greater than those of the other cultivars. The AC contents in the epidermis and achenes of the 'Keumhyang' were $74.0mg{\cdot}100g^{-1}$ FW and $36.7mg{\cdot}100g^{-1}$ DW, respectively, greater than those of the other cultivars. The EA content of the achenes of the 'Seolhyang' was $215.5mg{\cdot}100g^{-1}$ DW, significantly greater than those of the other cultivars. Results indicate that the antioxidant levels and other chemical compounds of strawberry fruits vary significantly among different fruit tissues. Our results also suggest that the recently introduced Korean 'Maehyang', 'Seolhyang', and 'Keumhyang' contain higher levels of antioxidants than other major June-bearing strawberry cultivars. These cultivars are feasible selections for both growers and consumers.

• Journal of Korean Medicine Rehabilitation
• /
• v.31 no.4
• /
• pp.117-127
• /
• 2021

Objectives Previously, we demonstrated that a 5% ethanol extract of unripe Rubus coreanus (5-uRCK) and ellagic acid has hypocholesterolemic and antiobesity activity in high-fat diet-fed animals. Therefore, we conducted a clinical study on the anti-obesity effect of 5-uRCK in 140 Korean adults (aged 19-70 years, body mass index (BMI) ≥25 kg/m²). Methods The participants were randomly assigned to two groups and were administered the placebo (n=70) or 5-uRCK extract (800 mg, n=70) daily for 12 weeks. The subjects were instructed to maintain their usual dietary intake and normal physical activity. Anthropometrics, body composition (dual-energy X-ray absorptiometry), and blood parameters were compared between the two groups. Results Average body weight and BMI did not show any significant changes; however, changes in upper body fat mass between the two groups was significantly different, as determined using analysis of covariance adjusted for baseline of percent body fat and drinking units. Moreover, Although not significant, the trunk fat mass and percent trunk fat tended to decrease after 5-uRCK supplementation. There was no significant difference in other laboratory biomarkers between the two groups. All safety parameters were within normal ranges in the both group. Conclusions In the present study, 5-uRCK significantly reduced upper body fat in obese subjects after 12 weeks, which indicates that it may help improve android-type obesity. Furthermore, the supplement is safe and well tolerated.

• Journal of the Korean Society of Food Science and Nutrition
• /
• v.44 no.4
• /
• pp.506-515
• /
• 2015

In this study, the effect of Goheung pomegranate extract on postmenopausal syndrome was evaluated both in vitro and in vivo in ovariectomized Sprague-Dawly (SD) rats. Sixty female SD rats were divided into six groups: sham, sham operation and distilled water; OVX, ovariectomized and distilled water; PE1, ovariectomized and pomegranate concentrate (0.75 mL/twice/d); PE2, ovariectomized and pomegranate concentrate (1.5 mL/twice/d); PE3, ovariectomized and pomegranate concentrate (2.2 mL/twice/d); and CE, ovariectomized and commercial pomegranate concentrate (2.2 mL/twice/d). Percent bone volume (bone volume/tissue volume) and trabecular thickness (Tb.Th) improved in a dose-independent manner in PE1, 2, and 3. Especially, bone mineral density was significantly improved in PE3 (P<0.05) compared to OVX. Pomegranate extract reduced body weight and visceral fat mass. High density lipoprotein cholesterol (HDL-C) level slightly increased in a dose-independent manner in the experimental group. In addition, HDL-C/total cholesterol level of PE3 significantly increased (P<0.05) compared with OVX. These results show that pomegranate concentrate improved blood lipid levels and bone metabolism in ovariectomized rats. Therefore, Goheung pomegranate concentrates are expected to improve cardiovascular and bone-related diseases in menopausal women.